Urothelial Cancer Response to Neoadjuvant Chemo Varies by Histologic Variant

Certain histologic variants of urothelial bladder cancer benefit more from neoadjuvant chemotherapy, according to a new study.

Source: CancerNetwork - August 3, 2017 Category: Cancer & Oncology Authors: Dave Levitan Tags: Bladder Cancer Genitourinary Cancers News Source Type: news